Celiac Test Accuracy: Blood Tests Miss About 1 in 10 Cases
Celiac blood tests are good, not perfect: tTG-IgA testing correctly identifies most people with celiac disease and correctly clears most people without it, but duodenal biopsy remains the reference standard for confirming a diagnosis. Accuracy depends heavily on staying on a normal, gluten-containing diet before testing and on checking your total IgA level. If your results are unclear or contradict your symptoms, further evaluation is the next step, not a guess.
TL;DR: tTG IgA detects about 90% to 93% of cases, while EMA specificity is about 99% and can confirm positive results when interpretation remains uncertain. Testing after gluten restriction can produce false negatives; a clinician may recommend a supervised challenge for two to six weeks before retesting. Clinicians should order tTG IgA with total IgA; deficiency makes IgA tests unreliable, so IgG tests such as DGP or tTG are used instead. Adults with tTG IgA above 10 times the lab limit may qualify for a no biopsy pathway after confirmation; borderline or discordant results need biopsy.
Precision Digestive HealthGet Clarity on Digestive HealthDr. Meet Parikh provides specialized gastroenterology care, including diagnostic endoscopy, for people seeking evaluation of digestive health concerns.Explore digestive care
Table of Contents
- How accurate are serologic tests? tTG-IgA, EMA, and DGP compared
- Key factors that affect test accuracy
- Role of biopsy and the evidence for no-biopsy approaches
- Testing algorithms and special clinical situations
- What to do before and after celiac testing: a step-by-step checklist
- Clinical perspective from Precision Digestive Health
- Why accurate testing matters
- Getting evaluated for celiac disease at Precision Digestive Health
- FAQ
- Sources
How accurate are serologic tests? tTG-IgA, EMA, and DGP compared
Tissue transglutaminase IgA (tTG-IgA) is the standard first-line blood test for celiac disease, and pooled data from systematic reviews show it performs well across populations.
Pooled analyses put tTG-IgA sensitivity around 90% to 93%, meaning the test misses roughly 1 in 10 people who actually have celiac disease, according to a comparative accuracy review.
Endomysial antibody (EMA) testing works differently. It is read under a microscope rather than measured by machine, which makes it labor-intensive but gives it very high specificity, reported at approximately 99%. That makes EMA a strong confirmatory test when a tTG-IgA result is positive but not overwhelmingly so. It is rarely used as a first-line screen because of its cost and the skill required to interpret it.
Deamidated gliadin peptide (DGP) antibodies fill a narrower role. In adults, DGP generally adds limited value once tTG-IgA has already been run, but it becomes useful in specific situations:
- Young children under two years old, where adding DGP IgG can improve sensitivity beyond tTG-IgA alone.
- Patients with IgA deficiency, where IgG-based DGP testing substitutes for the IgA assay.
- Cases where tTG-IgA results are borderline and additional serologic information helps guide next steps.
One detail that changes how doctors interpret a positive result is the titer itself. A tTG-IgA level far above the laboratory’s upper limit of normal (ULN), often cited as more than 10 times the ULN, carries a much higher positive predictive value than a result just barely over the cutoff. Because assay thresholds vary between labs, the raw number matters less than how it compares to that lab’s own reference range.
Key factors that affect test accuracy
Several variables can distort results in either direction, and most are avoidable once you know about them.
The biggest one is diet. Because celiac antibodies are a response to gluten exposure, testing while on a gluten-free diet can suppress antibody levels enough to cause a false negative. If you have already cut gluten, a supervised gluten challenge, typically a defined daily gluten intake for two to six weeks before retesting, can restore accuracy, but it needs medical oversight since symptoms often return during the challenge.
Total IgA deficiency is another common pitfall. If you are IgA deficient, standard IgA-based tests will read falsely negative regardless of disease status, which is why clinicians pair tTG-IgA with a total IgA measurement and switch to IgG-based assays when levels are low.
Other factors worth knowing:
- Disease stage and age can shift antibody levels, with early or milder disease sometimes producing weaker signals.
- Lab-to-lab assay variation means the same blood sample can yield different numeric results depending on the kit used.
- Point-of-care tests show lower and more variable accuracy than central laboratory assays and are not recommended as standalone diagnostic tools in adults.
Pro Tip: Ask your clinician which assay your lab uses and what its specific upper limit of normal is, since that number matters more than the raw antibody value by itself.
Role of biopsy and the evidence for no-biopsy approaches
Duodenal biopsy, taken during an upper endoscopy (EGD) with multiple samples from the small intestine, remains the clinical gold standard for confirming celiac disease in adults, as outlined in the Merck Manual’s professional guidance. Biopsy allows direct visualization of villous atrophy and the inflammatory changes that define the disease, which serology alone cannot show.
That said, a growing body of evidence supports a selective no-biopsy pathway in certain adults. Recent research on this conditional no-biopsy approach found that very high tTG titers, combined with confirmatory testing such as EMA or a repeat positive result, can carry a high positive predictive value, though that value shifts depending on the threshold and population studied.
Biopsy still has a clear role even where no-biopsy criteria exist. It remains necessary in these scenarios:
- Borderline or moderately elevated tTG titers that do not clear the high-confidence threshold.
- IgA deficiency, where antibody-based prediction models are less established.
- Discordant results, such as positive serology with negative genetic markers or unclear symptoms.
- Atypical presentations where the diagnosis is uncertain on clinical grounds alone.
Testing algorithms and special clinical situations
Clinicians generally follow a sequence rather than ordering every test at once, which keeps costs down and results interpretable.
- Start with tTG-IgA and a total IgA level drawn at the same time.
- If total IgA is low or deficient, switch to an IgG-based test, typically IgG DGP or IgG tTG.
- Add EMA as a confirmatory step when tTG-IgA is positive but the clinical picture is ambiguous.
- Consider HLA-DQ2/DQ8 genetic testing when the goal is to rule out celiac disease in a confusing case, since a negative result has high value for exclusion.
- In select adults with very high tTG titers, apply updated no-biopsy criteria, often using a threshold around 10 times the ULN, per recent society guidance.
Special situations change this sequence. Seronegative patients with strong symptoms or genetic risk may still need biopsy despite negative blood work. Patients already on a gluten-free diet need a supervised challenge before any test is meaningful. Immunosuppressed patients can have blunted antibody responses, which makes biopsy more important when suspicion remains high despite negative serology.
What to do before and after celiac testing: a step-by-step checklist
Getting an accurate result starts well before your blood draw.
- Do not start a gluten-free diet before testing. If you already have, talk to a clinician about undergoing appropriate supervised testing strategies rather than testing on a restricted diet.
- Ask for tTG-IgA plus total IgA on your initial panel, and confirm with your clinician whether IgG reflex testing applies to you if IgA is low.
- If serology comes back positive, or symptoms continue despite a negative result, request a referral to a gastroenterologist for possible EGD with biopsy.
- Keep copies of your lab reports and ask which assay was used and what reference range applies, since this context matters for interpreting borderline numbers.
Pro Tip: Bring your lab report to your gastroenterology appointment rather than just the result, so your clinician can see the assay type and reference range directly. For more on what to ask at that visit, our questions to bring to a gastroenterologist guide covers the specifics.
Clinical perspective from Precision Digestive Health
A typical celiac workup starts with a review of symptoms and prior test results, followed by serologic testing if it has not already been done correctly. When blood work and biopsy findings disagree, or when a patient has already removed gluten before testing, we walk through what repeat or confirmatory testing would involve. Our complete list of GI diagnostic tests gives a broader view of how celiac testing fits alongside other digestive workups. Anyone with discordant results or ongoing symptoms is encouraged to pursue specialist evaluation rather than live with uncertainty.
Why accurate testing matters
Misdiagnosis in either direction has real costs: an incorrect celiac diagnosis means decades of unnecessary dietary restriction, while a missed one leaves disease untreated. Careful, correctly timed testing protects against both outcomes.
— Precision Digestive Health
Getting evaluated for celiac disease at Precision Digestive Health
If your celiac testing came back positive, unclear, or inconsistent with your symptoms, our clinic offers the next step: a diagnostic workup that includes upper endoscopy with duodenal biopsy to confirm or rule out the disease, along with ongoing celiac disease management once a diagnosis is established. Prior lab work may also be reviewed to check whether testing conditions, like diet or IgA status, may have affected results.
If you are planning to eat gluten-free after a diagnosis, resources like gluten-free dining tips can help you navigate restaurants safely while you adjust. To schedule a consultation or review your results with our team, visit our services page to get started.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
FAQ
How accurate is bloodwork for celiac disease?
Celiac blood tests, primarily tTG-IgA, correctly identify most people with the disease, with pooled sensitivity around 90% to 93% and specificity generally above 95%. Accuracy depends on staying on a gluten-containing diet before testing and having normal total IgA levels, since deficiency or a gluten-free diet can distort results.
Can a celiac disease test be wrong?
Yes, both false negatives and false positives occur. The most common cause of a false negative is testing after gluten has already been reduced or eliminated, since antibody levels drop without ongoing gluten exposure, while IgA deficiency can also produce a falsely negative IgA-based result.
Can you have celiac even when the test is clear?
Yes, a negative serology result does not fully rule out celiac disease, particularly if you were not eating gluten regularly before testing or if you have IgA deficiency. Persistent symptoms despite negative blood work warrant further evaluation, which may include a supervised gluten challenge or duodenal biopsy.
How common is celiac misdiagnosis?
Misdiagnosis can happen in both directions: a missed diagnosis from testing on a gluten-free diet or during early disease, and an incorrect diagnosis from over-relying on borderline serology without biopsy confirmation. This is part of why guidelines emphasize testing on a normal diet and reserving no-biopsy diagnosis for patients with very high, well-confirmed antibody titers.
Is a gluten-free diet needed if testing is negative but symptoms continue?
Not necessarily, and starting one before a confirmed diagnosis can interfere with future testing. If symptoms persist despite negative celiac serology, our non-celiac gluten sensitivity guide explains other possibilities worth discussing with a gastroenterologist before changing your diet.
Sources
- Celiac Disease - Gastroenterology - Merck Manual Professional Edition
- Celiac disease – clinical tools and patient management (NIDDK)
- Comparative accuracy of diagnostic tests for celiac disease (AHRQ/NCBI summary)
- Accuracy of the No‑Biopsy Approach for the Diagnosis … (Gastroenterology journal article)
- European Society for the Study of Coeliac Disease 2025 updated guidelines (diagnostic approach)
